公開日期 | 題名 | 作者 | 關聯 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial | YC Hsu; CY Chen; IW Chang; CY Chang; CY Wu; TY Lee; MS Wu; MJ Bair; JJ Chen; CC Chen; CH Tseng; CM Tai; YT Huang ; WH Ku; LR Mo; JT Lin | LANCET INFECTIOUS DISEASES 21(6), 823-833 | |||
2018 | Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti‐viral therapy in patients with chronic hepatitis B | YC Hsu; T Jun; YT Huang ; ML Yeh; CL Lee; SH Cho; JT Lin; ML Yu; MH Nguyen; Y Tanaka | ALIMENTARY PHARMACOLOGY & THERAPEUTICS 48(10), 1128-1137 |